Literature DB >> 6970780

Inhibition of human natural cytotoxicity by macromolecular antiproteases.

D Hudig, T Haverty, C Fulcher, D Redelman, J Mendelsohn.   

Abstract

Human natural cell-mediated cytotoxicity is inhibited by macromolecular protease inhibitors. Human plasma alpha 1 antiproteases are more effective than the plant antiproteases lima bean trypsin inhibitor and soybean trypsin inhibitor for reduction of cytotoxicity to the "slow" targets T24 human bladder carcinoma and NKI-1 melanoma. This inhibition of natural cytotoxicity is more readily demonstrable in serum-free medium containing crystalline bovine serum albumin than in medium containing fetal calf serum. Although electrophoretically homogeneous plasma alpha 1 antitrypsin inhibits natural cytotoxicity, partially purified alpha 1 antitrypsin preparations that contain several apha 1 proteins are more inhibitory at equivalent trypsin inhibitory capacities. Partially purified alpha 1 antichymotrypsin with no antitrypsin activity is an extremely potent inhibitor. Thus, it seems likely that several of the plasma antiproteases, including alpha 1 antitrypsin and alpha 1 antichymotrypsin, are capable of influencing natural cytotoxicity. These data indicate that serine-dependent proteases hae a critical role in triggering and/or effecting cell-mediated cytolysis. Furthermore, since alpha 1 antichymotrypsin and alpha 1 antitrypsin are acute phase proteins, the increase in plasma concentration or turnover rates of the proteins could influence natural killer cell activity in vivo.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6970780

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Quantitative fluorescence measures for determination of intracellular perforin content.

Authors:  Kevin J Maher; Nancy G Klimas; Barry Hurwitz; Richard Schiff; Mary Ann Fletcher
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

2.  Granzymes, cytotoxic granules and cell death: the early work of Dr. Jurg Tschopp.

Authors:  J A Trapani
Journal:  Cell Death Differ       Date:  2011-11-18       Impact factor: 15.828

3.  Cloning and chromosomal assignment of a human cDNA encoding a T cell- and natural killer cell-specific trypsin-like serine protease.

Authors:  H K Gershenfeld; R J Hershberger; T B Shows; I L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

4.  Modifications of host defence mechanisms by an acute non-immunological inflammatory reaction.

Authors:  I Florentin; J Bird; Y Le Garrec; V Chung; J P Giroud
Journal:  Br J Exp Pathol       Date:  1985-06

5.  The primary elastase inhibitor (elastasin) and trypsin inhibitor (contrapsin) in the goat are serpins related to human alpha 1-anti-chymotrypsin.

Authors:  J Potempa; J J Enghild; J Travis
Journal:  Biochem J       Date:  1995-02-15       Impact factor: 3.857

6.  Involvement of cell surface macromolecules sensitive to alkylating ketones in lysis by human peripheral blood NK cells.

Authors:  M M Dawson; U Shipton; M Moore
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

7.  Safety of AAV factor IX peripheral transvenular gene delivery to muscle in hemophilia B dogs.

Authors:  Virginia Haurigot; Federico Mingozzi; George Buchlis; Daniel J Hui; Yifeng Chen; Etiena Basner-Tschakarjan; Valder R Arruda; Antoneta Radu; Helen G Franck; J Fraser Wright; Shangzhen Zhou; Hansell H Stedman; Dwight A Bellinger; Timothy C Nichols; Katherine A High
Journal:  Mol Ther       Date:  2010-04-27       Impact factor: 11.454

8.  Alpha-1-antichymotrypsin variant detected by PCR-single strand conformation polymorphism (PCR-SSCP) and direct sequencing.

Authors:  M Tsuda; Y Sei; M Matsumoto; H Kamiguchi; M Yamamoto; Y Shinohara; T Igarashi; M Yamamura
Journal:  Hum Genet       Date:  1992-12       Impact factor: 4.132

9.  Localization and identification of granzymes A and B-expressing cells in normal human lymphoid tissue and peripheral blood.

Authors:  J A Kummer; A M Kamp; T M Tadema; W Vos; C J Meijer; C E Hack
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

Review 10.  Immune responses to AAV vectors: overcoming barriers to successful gene therapy.

Authors:  Federico Mingozzi; Katherine A High
Journal:  Blood       Date:  2013-04-17       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.